In a move that could significantly reshape access to medical cannabis in Texas, lawmakers are debating House Bill 46 (HB 46), a proposal aimed at expanding the state’s Compassionate Use Program. The bill, which was recently brought before a Senate committee, has sparked both support and concern among legislators and advocates.
Currently, Texas’s Compassionate Use Program allows doctors to prescribe low-THC cannabis to patients with qualifying medical conditions, such as epilepsy, PTSD, and certain neurodegenerative diseases. HB 46 seeks to widen the scope of this program by increasing the number of licensed cannabis providers and introducing more flexible treatment options for patients.
One of the major changes under HB 46 would be the allowance of cannabis inhalers as a delivery method for medication. This form of administration could provide faster relief for patients compared to current methods, such as oils or capsules. Additionally, the bill would permit higher doses of THC per treatment, potentially offering stronger therapeutic effects for individuals with more severe conditions.
Another key element of HB 46 is its plan to raise the number of licensed dispensaries across the state to 11. Supporters argue that increasing the number of dispensaries would improve accessibility, especially for patients in rural or underserved areas who currently face significant travel barriers to obtain their medication. In contrast, the Senate’s companion bill, SB 1505, is more conservative, proposing to raise the number of dispensaries to just six.
Despite these proposed benefits, HB 46 is facing scrutiny due to its broader scope and potentially higher costs. Senator Charles Perry, who is sponsoring the bill in the Senate, acknowledged the financial concerns, indicating that the Senate version may proceed with more fiscal restraint.
Critics of HB 46 warn that expanding THC dosage and provider access too quickly could lead to regulatory challenges or unintended consequences. However, supporters counter that the current system is too restrictive and fails to meet the needs of thousands of patients who could benefit from medical cannabis.
As Texas continues to grapple with how best to regulate and expand medical cannabis access, HB 46 represents a critical juncture. The outcome of this debate could determine whether the state adopts a more progressive approach to compassionate care or continues on its cautious path.
For many patients and advocates, the hope is that lawmakers will strike a balance—ensuring safety and oversight while also delivering more comprehensive relief to those who need it most.
